Molecular Testing in the Community Setting
The evolution of biomarker–driven medicine is having an impact on oncology patient care—both diagnostically and therapeutically. To ensure that cancer programs are optimizing molecular testing processes, the Association of Community Cancer Centers (ACCC), in collaboration with Pfizer Oncology, launched a multi–phased initiative in 2012 titled, “Molecular Testing in the Community Oncology Setting.” Phase I consisted of member surveys and a published report that summarized key findings from the survey and outlined effective strategies to overcome common barriers.
In 2013, ACCC proceeded with Phase II, Learning Labs for Process Improvement, a program for member institutions that focused on improving molecular testing at the system level through experiential learning labs.
In 2013, ACCC proceeded with Phase II, Learning Labs for Process Improvement, a program for member institutions that focused on improving molecular testing at the system level through experiential learning labs. Eight member centers were elected to participate in this project:
- Anne Arundel Medical Center, DeCesaris Cancer Institute, Annapolis, Md.
- IU Health Goshen Center for Cancer Care, Goshen, Ind.
- Riverside Health System, Riverside Cancer Care Center, Newport News, Va.
- Shawnee Mission Medical Center, Shawnee Mission, Kans.
- Southside Regional Medical Center, Petersburg, Va.
- St. Vincent’s HealthCare, Jacksonville, Fla.
- The Methodist Hospitals, Oncology Services, Merrillville, Ind.
- The Thomas Johns Cancer Hospital, Richmond, Va.
Each center identified an administrator and a physician champion who helped gather baseline data, schedule the learning lab workshop, and hold follow–up meetings with the staff to monitor progress as they proceeded in the process–improvement journey.
View a recorded panel discussion, “Focus on Lung Cancer: From Screening to Diagnosis and Treatment,” that occurred at the ACCC National Oncology Conference, in San Diego, October 2014. Panelists cover learnings from two separate projects: 1) ACCC’s Learning Labs for Process Improvement project, as well as 2) The Biomarker Testing Service Redesign Project at St. Joseph Hospital, Orange County. Funding and support for both projects was provided by Pfizer, Inc.
Panel Moderator (on L): Joseph Kim, MD, MPH, MCM Education
Panelists (L to R): Wendy Holt, RN, MSN, OCN, St. Vincent's HealthCare; Cary Presant, MD, FACP, FASCO, City of Hope; Lawrence Wagman, MD, FACS, FPCS (Hon), St. Joseph Hospital of Orange
Phase 1 of ACCC's Molecular Testing in the Community Setting project took a three-pronged approach to inform challenges and effective practices in the use of molecular testing, including: development of an annotated bibliography, two informal online surveys (multidisciplinary team member survey and pathologist survey), and focus group and follow-up interviews. Learn more about the project and access a summary of the outcomes here.